Evidence for an essential role of cyclooxygenase-2 as a mediator of the late phase of ischemic preconditioning in mice

Y. Guo, W. Bao, W. J. Wu, K. Shinmura, X. L. Tang, R. Bolli

Research output: Contribution to journalArticle

92 Citations (Scopus)

Abstract

Recent studies have demonstrated that cyclooxygenase-2 (COX-2) is an essential mediator of the cardioprotective effects of the late phase of ischemic preconditioning (PC) in rabbits. The goal of this study was to determine whether COX-2 also plays an essential role in late PC in the mouse. B6129F2/J mice underwent a 30-min coronary occlusion followed by 24 h of reperfusion. Administration of the COX-2 selective inhibitor, NS-398, 30 min prior to the 30-min occlusion (5 mg/kg i.p.) had no appreciable effect on infarct size compared with untreated controls (58.8 ± 2.1 %, vs. 58.8 ± 4.3 % of the risk region, respectively). When mice were preconditioned with six cycles of 4-min coronary occlusion/4-min reperfusion 24 h prior to the 30-min occlusion, infarct size was markedly reduced (19.3 ± 3.4 %), indicating a late PC effect. The protective effect of late PC was completely abrogated by administration of NS-398 30 min before the 30-min coronary occlusion (67.7 ± 3.0 %), but not by administration of vehicle alone (23.6 ± 3.7 %). These results indicate that COX-2 mediates the late phase of ischemic PC in the mouse and imply that the role of this enzyme in cardioprotection is not species-specific.

Original languageEnglish
Pages (from-to)479-484
Number of pages6
JournalBasic Research in Cardiology
Volume95
Issue number6
DOIs
Publication statusPublished - 2000

Fingerprint

Ischemic Preconditioning
Cyclooxygenase 2
Coronary Occlusion
Reperfusion
Cyclooxygenase 2 Inhibitors
Rabbits
Enzymes
N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide

Keywords

  • COX-2
  • Ischemic preconditioning
  • Mice
  • Myocardial infarction

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Evidence for an essential role of cyclooxygenase-2 as a mediator of the late phase of ischemic preconditioning in mice. / Guo, Y.; Bao, W.; Wu, W. J.; Shinmura, K.; Tang, X. L.; Bolli, R.

In: Basic Research in Cardiology, Vol. 95, No. 6, 2000, p. 479-484.

Research output: Contribution to journalArticle

Guo, Y. ; Bao, W. ; Wu, W. J. ; Shinmura, K. ; Tang, X. L. ; Bolli, R. / Evidence for an essential role of cyclooxygenase-2 as a mediator of the late phase of ischemic preconditioning in mice. In: Basic Research in Cardiology. 2000 ; Vol. 95, No. 6. pp. 479-484.
@article{5f0f435728e34dd3beee0c6203e386eb,
title = "Evidence for an essential role of cyclooxygenase-2 as a mediator of the late phase of ischemic preconditioning in mice",
abstract = "Recent studies have demonstrated that cyclooxygenase-2 (COX-2) is an essential mediator of the cardioprotective effects of the late phase of ischemic preconditioning (PC) in rabbits. The goal of this study was to determine whether COX-2 also plays an essential role in late PC in the mouse. B6129F2/J mice underwent a 30-min coronary occlusion followed by 24 h of reperfusion. Administration of the COX-2 selective inhibitor, NS-398, 30 min prior to the 30-min occlusion (5 mg/kg i.p.) had no appreciable effect on infarct size compared with untreated controls (58.8 ± 2.1 {\%}, vs. 58.8 ± 4.3 {\%} of the risk region, respectively). When mice were preconditioned with six cycles of 4-min coronary occlusion/4-min reperfusion 24 h prior to the 30-min occlusion, infarct size was markedly reduced (19.3 ± 3.4 {\%}), indicating a late PC effect. The protective effect of late PC was completely abrogated by administration of NS-398 30 min before the 30-min coronary occlusion (67.7 ± 3.0 {\%}), but not by administration of vehicle alone (23.6 ± 3.7 {\%}). These results indicate that COX-2 mediates the late phase of ischemic PC in the mouse and imply that the role of this enzyme in cardioprotection is not species-specific.",
keywords = "COX-2, Ischemic preconditioning, Mice, Myocardial infarction",
author = "Y. Guo and W. Bao and Wu, {W. J.} and K. Shinmura and Tang, {X. L.} and R. Bolli",
year = "2000",
doi = "10.1007/s003950070024",
language = "English",
volume = "95",
pages = "479--484",
journal = "Basic Research in Cardiology",
issn = "0300-8428",
publisher = "D. Steinkopff-Verlag",
number = "6",

}

TY - JOUR

T1 - Evidence for an essential role of cyclooxygenase-2 as a mediator of the late phase of ischemic preconditioning in mice

AU - Guo, Y.

AU - Bao, W.

AU - Wu, W. J.

AU - Shinmura, K.

AU - Tang, X. L.

AU - Bolli, R.

PY - 2000

Y1 - 2000

N2 - Recent studies have demonstrated that cyclooxygenase-2 (COX-2) is an essential mediator of the cardioprotective effects of the late phase of ischemic preconditioning (PC) in rabbits. The goal of this study was to determine whether COX-2 also plays an essential role in late PC in the mouse. B6129F2/J mice underwent a 30-min coronary occlusion followed by 24 h of reperfusion. Administration of the COX-2 selective inhibitor, NS-398, 30 min prior to the 30-min occlusion (5 mg/kg i.p.) had no appreciable effect on infarct size compared with untreated controls (58.8 ± 2.1 %, vs. 58.8 ± 4.3 % of the risk region, respectively). When mice were preconditioned with six cycles of 4-min coronary occlusion/4-min reperfusion 24 h prior to the 30-min occlusion, infarct size was markedly reduced (19.3 ± 3.4 %), indicating a late PC effect. The protective effect of late PC was completely abrogated by administration of NS-398 30 min before the 30-min coronary occlusion (67.7 ± 3.0 %), but not by administration of vehicle alone (23.6 ± 3.7 %). These results indicate that COX-2 mediates the late phase of ischemic PC in the mouse and imply that the role of this enzyme in cardioprotection is not species-specific.

AB - Recent studies have demonstrated that cyclooxygenase-2 (COX-2) is an essential mediator of the cardioprotective effects of the late phase of ischemic preconditioning (PC) in rabbits. The goal of this study was to determine whether COX-2 also plays an essential role in late PC in the mouse. B6129F2/J mice underwent a 30-min coronary occlusion followed by 24 h of reperfusion. Administration of the COX-2 selective inhibitor, NS-398, 30 min prior to the 30-min occlusion (5 mg/kg i.p.) had no appreciable effect on infarct size compared with untreated controls (58.8 ± 2.1 %, vs. 58.8 ± 4.3 % of the risk region, respectively). When mice were preconditioned with six cycles of 4-min coronary occlusion/4-min reperfusion 24 h prior to the 30-min occlusion, infarct size was markedly reduced (19.3 ± 3.4 %), indicating a late PC effect. The protective effect of late PC was completely abrogated by administration of NS-398 30 min before the 30-min coronary occlusion (67.7 ± 3.0 %), but not by administration of vehicle alone (23.6 ± 3.7 %). These results indicate that COX-2 mediates the late phase of ischemic PC in the mouse and imply that the role of this enzyme in cardioprotection is not species-specific.

KW - COX-2

KW - Ischemic preconditioning

KW - Mice

KW - Myocardial infarction

UR - http://www.scopus.com/inward/record.url?scp=0034530260&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034530260&partnerID=8YFLogxK

U2 - 10.1007/s003950070024

DO - 10.1007/s003950070024

M3 - Article

C2 - 11192369

AN - SCOPUS:0034530260

VL - 95

SP - 479

EP - 484

JO - Basic Research in Cardiology

JF - Basic Research in Cardiology

SN - 0300-8428

IS - 6

ER -